Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pharmaceutical Equivalents

Pharmaceutical Equivalents

As defined by regulatory standards, pharmaceutical equivalents require generic drug products to have identical dosage forms and chemically identical active pharmaceutical ingredients (APIs). They must adhere to compendial or applicable standards for potency, content uniformity, disintegration times, and dissolution rates. In the case of modified-release dosage forms, variations in drug content are permissible as long as the delivered amount remains consistent with the innovator drug product.

Biopharmaceutics and Pharmacokinetics: Overview

Biopharmaceutics and Pharmacokinetics: Overview

Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the appropriate...

Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices

Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices

Parenteral drug delivery systems play a crucial role in modern therapeutics by enabling the direct administration of drugs into the systemic circulation, bypassing the gastrointestinal tract. These systems are particularly valuable for poorly absorbed oral medications that are unstable in the digestive environment or require rapid onset or sustained therapeutic levels. Delivery is achieved through intravenous, intramuscular, or subcutaneous routes, each selected based on the drug's properties...

Drug Distribution: Tissue Binding

Drug Distribution: Tissue Binding

Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...

Drug Administration and Therapy Phases: Overview

Drug Administration and Therapy Phases: Overview

Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Non-invasive cardiac radioablation for ventricular tachycardia: A feasibility dosimetric in silico study based on a prospective cohort of patients to compare photon to proton radiotherapy: Results of the Italian CARA-VT study.

Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)·2026

Same author

Proton therapy range uncertainty reduction using vendor-agnostic tissue characterization on a virtual photon-counting CT head scan.

Medical physics·2026

Same author

Microstructural modelling based on diffusion weighted imaging to guide dose painting in carbon ions for large sacral chordomas.

Physics and imaging in radiation oncology·2026

Same author

Inter-fraction dose and LET robustness in LET-optimized proton therapy for pediatric, adolescent and young adult intracranial tumors.

Medical physics·2025

Same author

Suitability of Polyacrylamide-Based Dosimetric Gel for Proton and Carbon Ion Beam Geometric Characterization.

Gels (Basel, Switzerland)·2025

Same author

Prognostic factors and clinical outcomes in a large cohort of head and neck adenoid cystic carcinoma patients treated with proton beam therapy: Insights from an Italian referral center.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2025

Search research articles

Related Experiment Video

Updated: Jun 1, 2026

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation

Published on: September 24, 2021

The athlete's pharmacy.

Mario Ciocca¹, Harry Stafford, Ronnie Laney

¹James A Taylor Campus Health Service, UNC Sports Medicine, University of North Carolina, Chapel Hill, NC 27599, USA. ciocca@email.unc.edu

Clinics in Sports Medicine

|June 11, 2011

Summary

This summary is machine-generated.

Young athletes may use legal but dangerous medications without medical advice. Physicians must understand these substances to educate athletes on risks and performance impacts.

More Related Videos

Intramuscular Injections Along the Motor End Plates: A Minimally Invasive Approach to Shuttle Tracers Directly into Motor Neurons

Intramuscular Injections Along the Motor End Plates: A Minimally Invasive Approach to Shuttle Tracers Directly into Motor Neurons

Published on: July 13, 2015

Related Experiment Videos

Last Updated: Jun 1, 2026

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation

Published on: September 24, 2021

Intramuscular Injections Along the Motor End Plates: A Minimally Invasive Approach to Shuttle Tracers Directly into Motor Neurons

Intramuscular Injections Along the Motor End Plates: A Minimally Invasive Approach to Shuttle Tracers Directly into Motor Neurons

Published on: July 13, 2015

Area of Science:

Sports Medicine
Pharmacology
Adolescent Health

Background:

Athletes utilize various substances for pain, illness, and performance enhancement.
A significant concern involves young athletes using potentially harmful legal medications without professional consultation.
Physicians require comprehensive knowledge of athlete medication use for informed care.

Purpose of the Study:

To highlight the risks associated with non-prescribed medication use in young athletes.
To emphasize the critical role of healthcare professionals in educating athletes about substance use.
To underscore the importance of understanding medication interactions with performance, exercise, and environment.

Main Methods:

Literature review on substance use in athletic populations.
Analysis of potential risks and benefits of common medications used by athletes.
Case study review of adverse events related to medication use in young athletes.

Main Results:

Many legal medications carry risks when used without medical supervision.
Lack of professional guidance can lead to adverse health outcomes and impaired performance.
Understanding individual athlete medication profiles is crucial for preventing negative interactions.

Conclusions:

Physicians must proactively inquire about and understand all substances athletes are using.
Comprehensive athlete education on medication risks and benefits is essential.
Informed medical guidance can mitigate dangers and optimize athlete health and performance.